Literature DB >> 18985993

Rapid effect of dexamethasone on the permeability of visceral sheep peritoneum.

Aggeliki Karioti1, Chrissi Hatzoglou, Sotirios Zarogiannis, Triantafyllia Deligiorgi, Vassilios Liakopoulos, Panagiota Kourti, Myrto Giannopoulou, Konstantinos Gourgoulianis, Paschalis-Adam Molyvdas, Ioannis Stefanidis.   

Abstract

The peritoneal mesothelium is a biologic barrier to water and ion transport. Its functional and structural integrity is crucial for peritoneal dialysis treatment. In vivo studies have shown that corticosteroids increase transcellular water transport and ultrafiltration of the rat peritoneum. In the present study, we used Ussing chamber technique to investigate the effect of dexamethasone on the transmesothelial permeability of the visceral sheep peritoneum in vitro. Peritoneal samples from the omentum of adult sheep were collected in a cooled and oxygenated Krebs-Ringer bicarbonate (KRB) solution immediately after the death of the animals. Isolated intact sheets were mounted in an Ussing-type chamber. Dexamethasone (10(-6) mol/L) and its inhibitor mifepristone (10(-5) mol/L) were added apically and basolaterally, alone and in combination to the KRB solution. The transmesothelial resistance (R) was measured for 1 hour before and serially after the addition of the substances. Data are expressed as mean +/- standard error of 6 experiments in each case. The control R was 21.5 +/- 0.42 omega x cm2. Dexamethasone induced a significant reduction of R within 15 minutes, which continued for the entire experiment. The maximum effect (% deltaR) was observed at 30 - 60 minutes after the addition of dexamethasone apically 46.2% +/- 7.14% (p < 0.01) and basolaterally 35.3% +/- 7.76% (p < 0.01). Mifepristone acted as an agonist on both sides of the membrane and significantly inhibited the dexamethasone effect. Our findings clearly indicate that dexamethasone rapidly increases the transmesothelial permeability of visceral sheep peritoneum. The rapid effect implicates dexamethasone and probably mifepristone as being involved in a common nongenomic pathway. Further investigation is necessary to elucidate the underlying mechanisms and perspectives of these findings.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18985993

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  4 in total

1.  Dexamethasone acutely accelerates pleural fluid absorption in mice hydrothoraces.

Authors:  Sotirios Zarogiannis; Ioannis Psallidas; Chrissi Hatzoglou; Konstantinos I Gourgoulianis; Ioannis Kalomenidis
Journal:  J Physiol Sci       Date:  2010-04-10       Impact factor: 2.781

2.  Dexamethasone decreases the transmesothelial electrical resistance of the parietal and visceral pleura.

Authors:  Sotirios Zarogiannis; Triantafyllia Deligiorgi; Ioannis Stefanidis; Vassilios Liakopoulos; Konstantinos Gourgoulianis; Paschalis Adam Molyvdas; Chrissi Hatzoglou
Journal:  J Physiol Sci       Date:  2009-05-22       Impact factor: 2.781

3.  Efficacy and safety of ultrasound-guided bleomycin combined with dexamethasone in the treatment of pediatric lymphangiomas.

Authors:  Yu-Tong Zhang; Chao Zhang; Yu Wang; Jian Chang
Journal:  Front Pediatr       Date:  2022-07-19       Impact factor: 3.569

Review 4.  Animal models in peritoneal dialysis.

Authors:  Olga Nikitidou; Vasiliki I Peppa; Konstantinos Leivaditis; Theodoros Eleftheriadis; Sotirios G Zarogiannis; Vassilios Liakopoulos
Journal:  Front Physiol       Date:  2015-09-01       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.